Cammarata E, Airoldi C, Colombo J, Ucciero A, Mastorino L, Arese V, et al. Impact of Disease Activity-Guided Dose Reduction on IL-17 and IL-23 Inhibitors in Psoriasis: A Real-World Assessment of Efficacy, Safety, and Economic Benefits. Dermatol Pract Concept [Internet]. 2025 Jul. 31 [cited 2026 Apr. 21];15(3):5845. Available from: https://dpcj.org/index.php/dpc/article/view/5845